13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000950123-25-008304
Total Value
$268.5M
Positions
8
Other Managers
3
Confidential Omitted
No
Holdings (8)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 4,628,225 | $127.7M | 47.56% |
| 2 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $43.9M | 16.34% |
| 3 | Sana Biotechnology Inc | SANA | 15,909,178 | $43.4M | 16.18% |
| 4 | Sana Biotechnology Inc | SANA | 9,092,678 | $24.8M | 9.25% |
| 5 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $15.7M | 5.85% |
| 6 | Seres Therapeutics Inc | MCRB | 733,207 | $8.1M | 3.03% |
| 7 | Seres Therapeutics Inc | MCRB | 422,643 | $4.7M | 1.75% |
| 8 | Moderna Inc | MRNA | 3,924 | $108,263 | 0.04% |